ALKS
Price
$27.25
Change
+$0.47 (+1.76%)
Updated
Mar 27, 6:59 PM EST
27 days until earnings call
DCPH
Price
$15.18
Change
+$0.36 (+2.43%)
Updated
Mar 27, 6:59 PM EST
34 days until earnings call
Ad is loading...

Compare predictions ALKS vs DCPH

Header iconALKS vs DCPH Comparison
Open Charts ALKS vs DCPHBanner chart's image
Alkermes
Price$27.25
Change+$0.47 (+1.76%)
Volume$881.49K
CapitalizationN/A
Deciphera Pharmaceuticals
Price$15.18
Change+$0.36 (+2.43%)
Volume$192.01K
CapitalizationN/A
View a ticker or compare two or three
ALKS vs DCPH Comparison Chart

Loading...

ALKSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DCPHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALKS vs. DCPH commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Hold and DCPH is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ALKS: $27.25 vs. DCPH: $15.19)
Brand notoriety: ALKS and DCPH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 83% vs. DCPH: 43%
Market capitalization -- ALKS: $4.55B vs. DCPH: $1.23B
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. DCPH’s [@Pharmaceuticals: Other] market capitalization is $1.23B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.16B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 1 FA rating(s) are green whileDCPH’s FA Score has 0 green FA rating(s).

  • ALKS’s FA Score: 1 green, 4 red.
  • DCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, ALKS is a better buy in the long-term than DCPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 3 TA indicator(s) are bullish while DCPH’s TA Score has 4 bullish TA indicator(s).

  • ALKS’s TA Score: 3 bullish, 6 bearish.
  • DCPH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DCPH is a better buy in the short-term than ALKS.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а -1.66% price change this week, while DCPH (@Pharmaceuticals: Other) price change was -3.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.45%. For the same industry, the average monthly price growth was +5.30%, and the average quarterly price growth was +13.33%.

Reported Earning Dates

ALKS is expected to report earnings on Apr 24, 2024.

DCPH is expected to report earnings on May 01, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+8.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for ALKS with price predictions.
OPEN
A.I.dvisor published
a Summary for DCPH with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALKS($4.55B) has a higher market cap than DCPH($1.23B). ALKS YTD gains are higher at: -1.766 vs. DCPH (-5.828). ALKS has higher annual earnings (EBITDA): 519M vs. DCPH (-208.86M). ALKS has more cash in the bank: 773M vs. DCPH (306M). DCPH has less debt than ALKS: DCPH (25.9M) vs ALKS (372M). ALKS has higher revenues than DCPH: ALKS (1.66B) vs DCPH (163M).
ALKSDCPHALKS / DCPH
Capitalization4.55B1.23B371%
EBITDA519M-208.86M-248%
Gain YTD-1.766-5.82830%
P/E Ratio8.91N/A-
Revenue1.66B163M1,020%
Total Cash773M306M253%
Total Debt372M25.9M1,436%
FUNDAMENTALS RATINGS
ALKS vs DCPH: Fundamental Ratings
ALKS
DCPH
OUTLOOK RATING
1..100
662
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
3297
PRICE GROWTH RATING
1..100
5959
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DCPH's Valuation (55) in the Biotechnology industry is somewhat better than the same rating for ALKS (98). This means that DCPH’s stock grew somewhat faster than ALKS’s over the last 12 months.

DCPH's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALKS (100). This means that DCPH’s stock grew similarly to ALKS’s over the last 12 months.

ALKS's SMR Rating (32) in the Biotechnology industry is somewhat better than the same rating for DCPH (97). This means that ALKS’s stock grew somewhat faster than DCPH’s over the last 12 months.

ALKS's Price Growth Rating (59) in the Biotechnology industry is in the same range as DCPH (59). This means that ALKS’s stock grew similarly to DCPH’s over the last 12 months.

ALKS's P/E Growth Rating (98) in the Biotechnology industry is in the same range as DCPH (100). This means that ALKS’s stock grew similarly to DCPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSDCPH
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
67%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
ALKSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DCPHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CRIT18.380.33
+1.83%
Optica Rare Earths & Critical Matrls ETF
NUV8.700.06
+0.69%
Nuveen Municipal Value Fund
OCTW33.850.04
+0.12%
AllianzIM US Large Cap Buffer20 Oct ETF
HIGH24.400.02
+0.07%
Simplify Enhanced Income ETF
RAYC13.40-0.10
-0.75%
Rayliant Quantamental China Equity ETF

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with VTRS. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
+1.76%
VTRS - ALKS
33%
Loosely correlated
+1.98%
ITCI - ALKS
30%
Poorly correlated
+3.58%
ACET - ALKS
30%
Poorly correlated
+3.57%
DCPH - ALKS
27%
Poorly correlated
+2.50%
NBIX - ALKS
27%
Poorly correlated
-2.42%
More

DCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DCPH has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DCPH jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DCPH
1D Price
Change %
DCPH100%
+2.50%
ACET - DCPH
39%
Loosely correlated
+3.57%
ESPR - DCPH
33%
Loosely correlated
-3.15%
SNDL - DCPH
29%
Poorly correlated
+10.66%
ALKS - DCPH
27%
Poorly correlated
+1.76%
NBIX - DCPH
27%
Poorly correlated
-2.42%
More